Modivcare INC DEF 14A proxy statements

ModivCare Inc. has filed its definitive proxy statement with the Securities and Exchange Commission.

ModivCare Inc. has released its proxy statement outlining proposals for the 2025 Annual Meeting of Stockholders, including the election of directors, executive compensation, and ratification of the independent auditor.

ModivCare Inc. has adjourned its Special Meeting of Stockholders to March 13, 2025, to ensure the release of its fourth quarter and full year 2024 financial results beforehand.

ModivCare Inc. has announced the adjournment of its special meeting of stockholders to March 13, 2025, to allow for the release of its fourth quarter and full year 2024 financial results beforehand.

ModivCare is holding a special stockholder meeting to approve a transaction involving the issuance of $30 million in new second lien notes and the exchange of $20.165 million of existing senior notes for new second lien notes with Coliseum Capital.

ModivCare obtains $105 million in incremental financing, appoints a Chief Transformation Officer, and initiates a strategic review of assets to bolster its financial position and future growth.

ModivCare Inc. has filed a definitive proxy statement with the Securities and Exchange Commission.

ModivCare Inc. has released its proxy statement outlining proposals for the 2024 Annual Meeting of Stockholders, including the election of directors and executive compensation.